Leap Therapeutics Inc. buy Raymond James
Start price
14.11.23
/
50%
€1.37
Target price
14.11.24
€16.21
Performance (%)
91.24%
End price
15.11.24
€2.62
Summary
This prediction ended on 15.11.24 with a price of €2.62. With a performance of 91.24% the BUY prediction by Raymond_James was a big success. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Leap Therapeutics Inc. | -18.110% | -18.110% | 9.244% |
| iShares Core DAX® | 0.754% | -1.027% | 14.485% |
| iShares Nasdaq 100 | -2.859% | -4.266% | 2.185% |
| iShares Nikkei 225® | 4.946% | 5.736% | 25.355% |
| iShares S&P 500 | -1.254% | -2.357% | 1.146% |
Comments by Raymond_James for this prediction
In the thread Leap Therapeutics Inc diskutieren
Leap Therapeutics, Inc. (NASDAQ: LPTX) had its price target lowered by analysts at Raymond James from $18.50 to $17.50. They now have an "outperform" rating on the stock.
Ratings data for LPTX provided by MarketBeat
In the thread Trading Leap Therapeutics Inc.
Die von Raymond_James gewählte maximale Laufzeit wurde überschritten